PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1193430
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1193430
Cell and Gene Therapy Thawing Equipment Market size was valued at USD 1,301.7 Million in 2022, expanding at a CAGR of 15.1% from 2023 to 2030.
Since many of the major market competitors are creating and introducing new solutions to increase their market share, technological advancements have made it simpler to produce equipment for cell and gene therapies. The market for cell and gene therapy thawing equipment has also expanded because of rising healthcare costs in developed and developing nations alike. Due to the rise in chronic diseases and technological development, the market for cell and gene therapy thawing equipment is expanding.
The market for cell and gene therapy equipment is driven by the rising incidence of chronic diseases. The need for cell and gene therapy thawing equipment declines because to an increase in the cost of cell and gene therapy engineering, which is limiting the market's expansion. The market for thawing equipment for cell and gene therapy is presented with an opportunity by the surge in fresh technical development. The lack of accessibility in low- and middle-income nations presents a challenge for the market growth for cell and gene therapy thawing equipment market.
Further, the growth of the cell and gene therapy thawing equipment market is being driven by the rise in cases of genetic illnesses like cardiac problems, cystic fibrosis, and AIDS, which necessitate the use of improved thawing equipment for cells and genes. Furthermore, the market for cell and gene therapy thawing equipment is expanding because to rising healthcare costs in both developed and developing nations. However, the growth of the market is anticipated to be hampered by high treatment costs, and challenges gene therapy diagnosis.
The Global Cell and Gene Therapy Thawing Equipment Market is segmented on the basis of Type, Application, End User, and Region.
The market is split into two categories based on Type: manual thawing system and automatic thawing system. The manual thawing system segment dominates the market. Growing demand for cell and gene therapeutics is mainly contributing to segment growth.
The market is segmented into two categories based on application: upstream processing and downstream processing. The upstream processing segment dominates the market and is likely to maintain its dominance during the forecast period. This is partly due to a rise in the demand for upstream cell and therapy needs.
The market is segmented into seven categories based on end user: blood banks and transfusion centers, hospitals and diagnostic laboratories, research and academic institutes, biotechnology and pharma, cord blood and stem cell banks, gene banks and others. The hospital and diagnostic laboratories segment dominate the market and is likely to maintain its dominance during the forecast period. This is partly due to an increase in the prevalence of genetic disorders which, in turn, is boosting the segment growth.
The worldwide market for cell and gene therapy thawing equipment is widely fragmented in nature which comprised of large and small-sized market players with few large dominating the global market share. The companies in market emphasize on adopting aggressive strategies to reach out large consumer base. Some of the primary techniques used by corporations to strengthen their reach and expand their market share include new distribution network, research spending, and mergers and acquisitions.
For instance, In October 2023, Azenta Life Sciences, a leading provider of life sciences solutions worldwide, hosted the Cryogenic Considerations for Cell and Gene Therapy Symposium in Boston to promote and create awareness about thawing of advanced therapies.
Key features of the study:
This proposed research study on Cell and Gene Therapy Thawing Equipment market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Cell and Gene Therapy Thawing Equipment market
The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Cell and Gene Therapy Thawing Equipment market
Impact of COVID-19 on Cell and Gene Therapy Thawing Equipment market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Cell and Gene Therapy Thawing Equipment market post-COVID will also be covered.
In order to give the users of this report a comprehensive view on the Cell and Gene Therapy Thawing Equipment market, we have also included competitive landscape and key innovator analysis for the Cell and Gene Therapy Thawing Equipment market.
The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Cell and Gene Therapy Thawing Equipment market.
In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
The global Cell and Gene Therapy Thawing Equipment market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET KEY PLAYERS
Pluristem Therapeutics Inc.
Glenmark Pharmaceutical Inc.
SARSTEDT AG & Co. KG
Helmer Scientific Inc.
GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE
Manual thawing system
Automatic thawing system
GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION
GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER
Blood banks and transfusion centers
Hospitals and diagnostic laboratories
Research and academic institutes
Biotechnology and pharma
Cord blood and stem cell banks
GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION
Rest of Europe
Rest of APAC
Rest of LATAM
The Middle East and Africa
United Arab Emirates
Rest of MEA